SYDNEY, AUSTRALIA and BERLIN and NEW CANAAN, CT--(Marketwire - October 23, 2007) - A symposium on platinum resistant ovarian cancer will be held at the European Society for Gynecological Oncology in Berlin on Sunday, 28 October. Leading cancer researchers will speak at the symposium which will focus on advances in platinum therapies and the potential for phenoxodiol as a promising new investigational drug to restore platinum sensitivity in platinum resistant ovarian cancer. Medical professionals interested in listening to the symposium via the Internet can register for free at http://www.ovaturetrial/ESGOsymposium.com.
